NO20010786L - TPL-2/COT kinase og fremgangsmåter for anvendelse - Google Patents

TPL-2/COT kinase og fremgangsmåter for anvendelse

Info

Publication number
NO20010786L
NO20010786L NO20010786A NO20010786A NO20010786L NO 20010786 L NO20010786 L NO 20010786L NO 20010786 A NO20010786 A NO 20010786A NO 20010786 A NO20010786 A NO 20010786A NO 20010786 L NO20010786 L NO 20010786L
Authority
NO
Norway
Prior art keywords
tpl
methods
cot kinase
cot
kinase
Prior art date
Application number
NO20010786A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010786D0 (no
Inventor
Hamish John Allen
Richard Woodward Dixon
Joanne Sara Kamens
Dineli Wickramasinghe
Yajun Xu
Monica Polidoro Belich
Leland Herries Johnston
Steven Charles Ley
Andres Salmeron
Original Assignee
Basf Ag
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9817930.2A external-priority patent/GB9817930D0/en
Priority claimed from GBGB9827712.2A external-priority patent/GB9827712D0/en
Application filed by Basf Ag, Medical Res Council filed Critical Basf Ag
Publication of NO20010786D0 publication Critical patent/NO20010786D0/no
Publication of NO20010786L publication Critical patent/NO20010786L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
NO20010786A 1998-08-18 2001-02-16 TPL-2/COT kinase og fremgangsmåter for anvendelse NO20010786L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9817930.2A GB9817930D0 (en) 1998-08-18 1998-08-18 Pathway
GBGB9827712.2A GB9827712D0 (en) 1998-12-16 1998-12-16 Pathway
PCT/US1999/018543 WO2000011191A2 (en) 1998-08-18 1999-08-13 Tpl-2/cot kinase and methods of use

Publications (2)

Publication Number Publication Date
NO20010786D0 NO20010786D0 (no) 2001-02-16
NO20010786L true NO20010786L (no) 2001-04-17

Family

ID=26314223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010786A NO20010786L (no) 1998-08-18 2001-02-16 TPL-2/COT kinase og fremgangsmåter for anvendelse

Country Status (22)

Country Link
US (1) US20020099169A1 (xx)
EP (1) EP1105501A2 (xx)
JP (1) JP4719831B2 (xx)
KR (1) KR20010085407A (xx)
CN (1) CN1323346A (xx)
AU (1) AU767973B2 (xx)
BG (1) BG105345A (xx)
BR (1) BR9913070A (xx)
CA (1) CA2339036A1 (xx)
CZ (1) CZ2001625A3 (xx)
HK (1) HK1041901A1 (xx)
HU (1) HUP0103797A2 (xx)
ID (1) ID28955A (xx)
IL (1) IL141355A0 (xx)
MX (1) MXPA01001747A (xx)
NO (1) NO20010786L (xx)
NZ (1) NZ510313A (xx)
PL (1) PL347137A1 (xx)
RU (1) RU2001107122A (xx)
SK (1) SK2242001A3 (xx)
TR (2) TR200103840T2 (xx)
WO (1) WO2000011191A2 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660906B1 (en) 2000-03-08 2003-12-09 Thomas Jefferson University Tpl2 transgenic knockout mice
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
GB0402661D0 (en) * 2004-02-06 2004-03-10 Medical Res Council TPL2 and its expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514505A (en) * 1995-05-15 1996-05-07 Xerox Corporation Method for obtaining improved image contrast in migration imaging members
UA71889C2 (uk) * 1996-04-02 2005-01-17 Йєда Рісерч Енд Дівелопмент Ко. Лтд. Модулятори зв'язаного з рецептором tnf фактора (traf), їх одержання та застосування

Also Published As

Publication number Publication date
CZ2001625A3 (cs) 2002-02-13
HK1041901A1 (zh) 2002-07-26
KR20010085407A (ko) 2001-09-07
EP1105501A2 (en) 2001-06-13
MXPA01001747A (es) 2003-06-06
CA2339036A1 (en) 2000-03-02
IL141355A0 (en) 2002-03-10
ID28955A (id) 2001-07-19
BR9913070A (pt) 2001-05-08
US20020099169A1 (en) 2002-07-25
TR200103840T2 (tr) 2002-06-21
WO2000011191A2 (en) 2000-03-02
RU2001107122A (ru) 2003-04-20
CN1323346A (zh) 2001-11-21
AU767973B2 (en) 2003-11-27
WO2000011191A3 (en) 2000-06-08
PL347137A1 (en) 2002-03-25
NO20010786D0 (no) 2001-02-16
TR200100624T2 (tr) 2001-08-21
JP4719831B2 (ja) 2011-07-06
AU5563399A (en) 2000-03-14
HUP0103797A2 (hu) 2003-10-28
SK2242001A3 (en) 2001-10-08
JP2002531058A (ja) 2002-09-24
BG105345A (en) 2001-12-31
NZ510313A (en) 2003-11-28

Similar Documents

Publication Publication Date Title
IS6411A (is) Kaspasa tálmar og notkun þeirra
NO972125L (no) Hemorroideblandinger og fremgangsmåte for anvendelse
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
AU7593001A (en) Alpha-msh related compounds and methods of use
DE10080052T1 (de) Beratungshilfeverfahren und -einrichtungen
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
NO20024099D0 (no) Lavdose entecavir-formulering og anvendelse
DK1041879T4 (da) Desinfektionsmiddel og fremstillingsmetode
NO991150L (no) Pyrazolopyrimidiner og pyrazolotriaziner
NO20004778D0 (no) Amidderivater og nociceptin antagonister
NO994778L (no) Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom
NO20023342L (no) Fremgangsmåte for fjernelse av NOX og N2O
NO20021412D0 (no) Soyamelkeblandinger og fremgangsmåter for fremstilling
IL162328A0 (en) Adjustable chair and method of use
NO20003067L (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO972477D0 (no) Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse
NO983576L (no) Br°nnbehandlingsfluider og fremgangsmÕter
NO980718D0 (no) Bicykliske 4-aralkylaminopyrimidinderivater og tyrosinkinaseinhibitorer
BR9705018A (pt) Travesseiro e colchão anatômicos
NO20033506D0 (no) Parasittdrepende preparater og fremgangsmåter for anvendelse
NO20010464L (no) FremgangsmÕter og preparater for behandling av gastro- øsofagealt-reflukssyndrom
NO20023737L (no) Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application